Menu Back toSession 7: How Can Clinical Trial Innovative Designs Accelerate Medical Innovation for Patients?

Latin America Regulatory Conference


Session 7: How Can Clinical Trial Innovative Designs Accelerate Medical Innovation for Patients?

Session Chair(s)

Sonia  Viejobueno, LLM

Sonia Viejobueno, LLM

  • Latin America Lead, Global Regulatory Policy and Intelligence
  • The Janssen Pharmaceutical Companies of Johnson & Johnson, Argentina
Renata De Lima Soares

Renata De Lima Soares

  • Regulation and Health Surveillance Specialist
  • Anvisa, Brazil
In contrast to traditional trial designs, where a single drug is tested in a single disease population in one clinical trial, designs such as master protocols use a single infrastructure, trial design, and protocol to simultaneously evaluate multiple drugs and/or disease populations in multiple sub-studies, that may contain an adaptive design.
We will discuss Innovative Clinical Trials design, including Basket, Umbrella, Platform and Adaptive Clinical Trials and how they are contributing to accelerate patient access to new medicines and improve the efficiency and the success rate of clinical trials.
Learning Objective : At the conclusion of this session, participants should be able to:
  • Understand basic concepts of Innovative Clinical Trials Design and their importance for current drug development
  • Obtain greater understanding of Innovative Clinical Trials Design and how can industry and regulators across Latin America collaborate to support their implementation in the region

Speaker(s)

John  Scott, PhD, MA

Speaker

John Scott, PhD, MA

  • Director, Division of Biostatistics, OBE, CBER
  • FDA, United States
Laura Giselle Traversi, MD

Clinical Trial Innovative designs: Regulatory Agency Perspective

Laura Giselle Traversi, MD

  • Head of Clinical Trials Department
  • ANMAT, Argentina
Gustavo  Mendes Lima Santos, MPharm

Speaker

Gustavo Mendes Lima Santos, MPharm

  • General Manager of Medicines and Biological Products
  • ANVISA, Brazil
Telba  Irony, PhD, MS, MSc

Speaker

Telba Irony, PhD, MS, MSc

  • Senior Scientific Director, Quantitative Sciences
  • Janssen R&D, United States

Contact us

Registration Questions?

Send Email
1.888.257.6457


On Demand Content Preview Webinar

Registration Pathways to Accelerate Regulatory Assessment of Innovative Medicines in Latin America
Register Today!